Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
Open Access
- 1 June 2010
- journal article
- Published by FapUNIFESP (SciELO) in Archives of Endocrinology and Metabolism
- Vol. 54 (4) , 362-368
Abstract
OBJECTIVE: To evaluate the frequency of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (DM2) and to describe its risk factors. SUBJECTS AND METHODS: Blood samples of 78 patients were collected for assessment of glycemic and lipid profile, liver enzymes, TNF-α and HOMA-IR. The diagnosis of NAFLD was established by ultrasound. RESULTS: NAFLD was observed in 42% of patients who had greater BMI (p < 0.001), and frequency of hypertension (p < 0.001). Metabolic syndrome was more frequent in those with NAFLD (p = 0.019). The levels of aspartate, alanine aminotransferase, γ-glutamyl transpeptidase, uric acid, TNF-α, insulin and HOMA-IR were significantly higher in patients with NAFLD than those without NAFLD. CONCLUSION: Almost half of patients with DM2 were found to have NAFLD, and they have more elevated BMI, as well as higher levels of aminotransferases, γ-GT, uric acid, TNF-α, insulin and HOMA-IR than subjects without NAFLD.Keywords
This publication has 37 references indexed in Scilit:
- Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implicationsArchives of Endocrinology and Metabolism, 2009
- Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and managementWorld Journal of Gastroenterology, 2009
- Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patientsDiabetologia, 2007
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic PatientsDiabetes Care, 2007
- Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver DiseaseDiabetes Care, 2007
- Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Nonalcoholic fatty liver diseaseCanadian Medical Association Journal, 2005
- Global Prevalence of DiabetesDiabetes Care, 2004
- Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic ConferenceHepatology, 2003
- Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.Diabetes Care, 1999